EdgarLookup

AGILENT TECHNOLOGIES, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AGILENT TECHNOLOGIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
29.1%
Profit Margin
Net income ÷ revenue
10.2%
Return on Assets
Net income ÷ assets
0.89x
Debt-to-Equity
Total liabilities ÷ equity
+6.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2017 Oct 31, 2017 $4.47B Dec 21, 2017
FY2017 Oct 31, 2016 $4.20B Dec 21, 2017
FY2017 Oct 31, 2015 $4.04B Dec 21, 2017
FY2016 Oct 31, 2014 $4.05B Dec 20, 2016
FY2015 Oct 31, 2013 $3.89B Dec 21, 2015
FY2012 Oct 31, 2012 $6.86B Dec 20, 2012
FY2012 Oct 31, 2011 $6.62B Dec 20, 2012
FY2012 Oct 31, 2010 $5.44B Dec 20, 2012
FY2011 Oct 31, 2009 $4.48B Dec 16, 2011

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $6.95B Dec 22, 2025
FY2025 Oct 31, 2024 $6.51B Dec 22, 2025
FY2025 Oct 31, 2023 $6.83B Dec 22, 2025
FY2024 Oct 31, 2022 $6.85B Dec 20, 2024
FY2023 Oct 31, 2021 $6.32B Dec 20, 2023
FY2022 Oct 31, 2020 $5.34B Dec 21, 2022
FY2021 Oct 31, 2019 $5.16B Dec 17, 2021
FY2020 Oct 31, 2018 $4.91B Dec 18, 2020
FY2019 Oct 31, 2017 $4.47B Dec 19, 2019
FY2018 Oct 31, 2016 $4.20B Dec 20, 2018

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Oct 31, 2017 $4.47B Dec 21, 2017
FY2017 Oct 31, 2016 $4.20B Dec 21, 2017
FY2017 Oct 31, 2015 $4.04B Dec 21, 2017
FY2016 Oct 31, 2014 $4.05B Dec 20, 2016
FY2015 Oct 31, 2013 $3.89B Dec 21, 2015
FY2014 Oct 31, 2012 $6.86B Dec 22, 2014
FY2013 Oct 31, 2011 $6.62B Dec 19, 2013
FY2012 Oct 31, 2010 $5.44B Dec 20, 2012
FY2011 Oct 31, 2009 $4.48B Dec 16, 2011
FY2010 Oct 31, 2008 $5.77B Dec 20, 2010

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $1.30B Dec 22, 2025
FY2025 Oct 31, 2024 $1.29B Dec 22, 2025
FY2025 Oct 31, 2023 $1.24B Dec 22, 2025
FY2024 Oct 31, 2022 $1.25B Dec 20, 2024
FY2023 Oct 31, 2021 $1.21B Dec 20, 2023
FY2022 Oct 31, 2020 $719.00M Dec 21, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $1.48B Dec 22, 2025
FY2025 Oct 31, 2024 $1.49B Dec 22, 2025
FY2025 Oct 31, 2023 $1.35B Dec 22, 2025
FY2024 Oct 31, 2022 $1.62B Dec 20, 2024
FY2023 Oct 31, 2021 $1.35B Dec 20, 2023
FY2022 Oct 31, 2020 $846.00M Dec 21, 2022
FY2021 Oct 31, 2019 $941.00M Dec 17, 2021
FY2020 Oct 31, 2018 $904.00M Dec 18, 2020
FY2019 Oct 31, 2017 $807.00M Dec 19, 2019
FY2018 Oct 31, 2016 $615.00M Dec 20, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $12.73B Dec 22, 2025
FY2025 Oct 31, 2024 $11.85B Dec 22, 2025
FY2024 Oct 31, 2023 $10.76B Dec 20, 2024
FY2023 Oct 31, 2022 $10.53B Dec 20, 2023
FY2022 Oct 31, 2021 $10.71B Dec 21, 2022
FY2021 Oct 31, 2020 $9.63B Dec 17, 2021
FY2020 Oct 31, 2019 $9.45B Dec 18, 2020
FY2019 Nov 1, 2018 $8.56B Dec 19, 2019
FY2019 Oct 31, 2018 $8.54B Dec 19, 2019
FY2018 Oct 31, 2017 $8.43B Dec 20, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $5.99B Dec 22, 2025
FY2025 Oct 31, 2024 $5.95B Dec 22, 2025
FY2024 Oct 31, 2023 $4.92B Dec 20, 2024
FY2023 Oct 31, 2022 $5.23B Dec 20, 2023
FY2022 Oct 31, 2021 $5.32B Dec 21, 2022
FY2021 Oct 31, 2020 $4.75B Dec 17, 2021
FY2020 Oct 31, 2019 $4.70B Dec 18, 2020
FY2019 Nov 1, 2018 $3.96B Dec 19, 2019
FY2019 Oct 31, 2018 $3.97B Dec 19, 2019
FY2018 Oct 31, 2017 $3.59B Dec 20, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $6.74B Dec 22, 2025
FY2025 Oct 31, 2024 $5.90B Dec 22, 2025
FY2024 Oct 31, 2023 $5.85B Dec 20, 2024
FY2023 Oct 31, 2022 $5.31B Dec 20, 2023
FY2022 Oct 31, 2021 $5.39B Dec 21, 2022
FY2021 Oct 31, 2020 $4.87B Dec 17, 2021
FY2020 Oct 31, 2019 $4.75B Dec 18, 2020
FY2019 Nov 1, 2018 $4.59B Dec 19, 2019
FY2019 Oct 31, 2018 $4.57B Dec 19, 2019
FY2018 Oct 31, 2017 $4.83B Dec 20, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 4 Dec 22, 2025
FY2025 Oct 31, 2024 4 Dec 22, 2025
FY2025 Oct 31, 2023 4 Dec 22, 2025
FY2024 Oct 31, 2022 4 Dec 20, 2024
FY2023 Oct 31, 2021 3 Dec 20, 2023
FY2022 Oct 31, 2020 2 Dec 21, 2022
FY2021 Oct 31, 2019 3 Dec 17, 2021
FY2020 Oct 31, 2018 0 Dec 18, 2020
FY2019 Oct 31, 2017 2 Dec 19, 2019
FY2018 Oct 31, 2016 1 Dec 20, 2018

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 4 Dec 22, 2025
FY2025 Oct 31, 2024 4 Dec 22, 2025
FY2025 Oct 31, 2023 4 Dec 22, 2025
FY2024 Oct 31, 2022 4 Dec 20, 2024
FY2023 Oct 31, 2021 3 Dec 20, 2023
FY2022 Oct 31, 2020 2 Dec 21, 2022
FY2021 Oct 31, 2019 3 Dec 17, 2021
FY2020 Oct 31, 2018 0 Dec 18, 2020
FY2019 Oct 31, 2017 2 Dec 19, 2019
FY2018 Oct 31, 2016 1 Dec 20, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $1.79B Dec 22, 2025
FY2025 Oct 31, 2024 $1.33B Dec 22, 2025
FY2025 Oct 31, 2023 $1.59B Dec 22, 2025
FY2024 Oct 31, 2022 $1.05B Dec 20, 2024
FY2023 Oct 31, 2021 $1.48B Dec 20, 2023
FY2022 Oct 31, 2020 $1.44B Dec 21, 2022
FY2021 Oct 31, 2019 $1.38B Dec 17, 2021
FY2019 Nov 1, 2018 $2.25B Dec 19, 2019
FY2020 Oct 31, 2018 $2.25B Dec 18, 2020
FY2019 Oct 31, 2017 $2.68B Dec 19, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Oct 31, 2025 $3.05B Dec 22, 2025
FY2025 Oct 31, 2024 $3.35B Dec 22, 2025
FY2024 Oct 31, 2023 $2.74B Dec 20, 2024
FY2023 Oct 31, 2022 $2.73B Dec 20, 2023
FY2022 Oct 31, 2021 $2.73B Dec 21, 2022